Relationships between induction of apoptosis by Taxol in Hela cells and apoptosis-related proteins

Chinese Pharmacological Bulletin

Volumn 20, Issue 9, 2004, Pages 1066-1067

  Hu, Xiang Yang ^a   Meng, Gang ^a   Bao, Yang Yi ^b   Zhu, Xiao Mei ^b   Wang, Yuan ^a   Zhou, Qing ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b Hefei First People's Hospital   (China)

Author keywords

Apoptosis; Caspase 3; Hela; PCNA; Taxol

Indexed keywords

CASPASE 3; ENZYME; PACLITAXEL; PROTEIN;

APOPTOSIS; CELL DEATH; FLOW CYTOMETRY; HELA CELL; HUMAN; NICK END LABELING;

EID: 33845508232     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Micheau O, Solary E, Hammann A et al. Sensitization of cancer cells treated with cytotoxic drugs to Fas-mediated cytotoxicity [J]. J Natl Cancer Inst, 1997, 89: 783-9.
2. Judson PL, Watson JM, Gehrig PA et al. Cisplatin inhibits paclitaxel-induced apoptosis in cisplatin-resistant ovarian cancer cell lines: possible explanation for failure of combination therapy [J]. Cancer Res, 1999, 59(10): 2425-32.
3. Panvichian R, Orth K, Day ML, et al. Paclitaxel-associated multi-mininucleation is permitted by the inhibition of caspase activation: a potential early step in drug resistance [J]. Cancer Res, 1998, 58 (20); 4667-72.
4. Nagase Y, Moriyama N, Kurimoto S, et al. Histochemical expression of proliferating cell nuclear antigen (PCNA) for pre and post chemotherapeutic bladder cancer [J]. Nippon Hinyokika Gakkai Zasshi, 1995, 86(5): 985-90.
5. Haneda H, Katabami M, Miyamoto H. The relationship of the proliferating cell nuclear antigen protein to cis-diamminedichloroplatinum (II) resistance of a murine leukemia cell line. P388/CDDP [J]. Oncology, 1991, 48(3): 234-8.
6. Porter AG, Janicke RU. Emerging roles of caspase-3 in apoptosis [J]. Cell Death Differ, 1999, 6(2): 99-104.